Although systemic dissemination has been suggested as a potential drawback of anticoagulant treatment in pneumonia [40], local treatment with rh-TFPI did not influence bacterial counts in the lung or systemic compartment. The gene discussed is TFPI; the disease is susceptibility to pneumonia measurement.